Russia announces more deals to produce Sputnik V vaccine in EU

Russia announces more deals to produce Sputnik V vaccine in EU
Russia announces more deals to produce Sputnik V vaccine in EU

We show you our most important and recent visitors news details Russia announces more deals to produce Sputnik V vaccine in EU in the following article

Hind Al Soulia - Riyadh - MOSCOW — Russia says it has reached new agreements to produce the Sputnik V COVID-19 vaccine in more EU countries. Deals have been reached with companies in Spain, France, and Germany pending its approval in the EU, according to the Russian Direct Investment Fund (RDIF).

"Currently there are additional talks ongoing to boost production in the EU," the fund's head, Kirill Dmitriev, said in a statement. "This will allow us to start supplying Sputnik V to the European single market once the approval is granted by the European Medicines Agency (EMA)."

Last week, the Italian-Swiss pharmaceutical company Adienne in Lombardy announced the first production agreement to make the Sputnik V vaccine from July. The RDIF, which financed the development of the vaccine, has not named the companies in France, Germany, and Spain it has reached agreements with.

Sputnik V is not yet authorized in the European Union, but the EMA has begun a rolling review based on results from laboratory studies and clinical studies in adults. Following the announcement, the Russian authorities said they were ready to provide vaccines to 50 million Europeans from June.

In addition, Dmitriev said that Russia was also ready to "start supplying those EU countries that had authorized Sputnik V independently", such as Hungary.

"Since the start of the fight against the pandemic, the RDIF has been in favor of active coordination with all partners, including from Europe, and open to negotiations," he added.

The Sputnik V jab was initially greeted with skepticism in Europe after it was unveiled in the summer of 2020 after limited clinical tests. But a study published in the scientific medical journal, The Lancet, has shown that the vaccine is 91.6% effective against symptomatic cases of COVID-19.

Last week, Russia questioned the neutrality of the EMA after a senior official urged EU member states not to use the Sputnik V vaccine yet. The development of the vaccine was entrusted to state institutions and is celebrated in Moscow as a historic success for President Vladimir Putin's Russia. — Euronews


These were the details of the news Russia announces more deals to produce Sputnik V vaccine in EU for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Saudi Gazette and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV WFP reaches deal to supply food to 185,000 children in Venezuela
NEXT Shackling of aged and infirmed inmate Abu-Jamal ‘deplorable’ — UN